Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gam

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
CpG oligodeoxynucleotides as vaccine adjuvants in primatesDaniela Verthelyi, Richard T Kenney, Robert A Seder, et al.
Infection and Immunity|March 26, 2003
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activationSylvie Bertholet, Harold L Dickensheets, Faruk Sheikh, et al.
The American Journal of Tropical Medicine and Hygiene|September 20, 2001
Resistance to treatment in Kala-azar: speciation of isolates from northeast IndiaS Sundar, K Pai, R Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasisR T Kenney, D L Sacks, J P Sypek, et al.
The Cochrane Database of Systematic Reviews|June 14, 2003
Low level laser therapy (Classes I, II and III) for treating osteoarthritisL Brosseau, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Low level laser therapy (Classes I, II and III) for treating osteoarthritisL Brosseau, V Welch, G Wells, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 27, 2005
Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteinsW J J Finlay, N C deVore, E N Dobrovolskaia, et al.
The Journal of Infectious Diseases|November 17, 1998
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralisF A Neva, J O Filho, A A Gam, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritisL Brosseau, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|October 20, 2005
Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritisL Brosseau, V Robinson, G Wells, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
CpG oligodeoxynucleotides as vaccine adjuvants in primatesDaniela Verthelyi, Richard T Kenney, Robert A Seder, et al.
Infection and Immunity|March 26, 2003
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activationSylvie Bertholet, Harold L Dickensheets, Faruk Sheikh, et al.
The American Journal of Tropical Medicine and Hygiene|September 20, 2001
Resistance to treatment in Kala-azar: speciation of isolates from northeast IndiaS Sundar, K Pai, R Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasisR T Kenney, D L Sacks, J P Sypek, et al.
The Cochrane Database of Systematic Reviews|June 14, 2003
Low level laser therapy (Classes I, II and III) for treating osteoarthritisL Brosseau, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Low level laser therapy (Classes I, II and III) for treating osteoarthritisL Brosseau, V Welch, G Wells, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 27, 2005
Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteinsW J J Finlay, N C deVore, E N Dobrovolskaia, et al.
The Journal of Infectious Diseases|November 17, 1998
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralisF A Neva, J O Filho, A A Gam, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritisL Brosseau, V Welch, G Wells, et al.
The Cochrane Database of Systematic Reviews|October 20, 2005
Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritisL Brosseau, V Robinson, G Wells, et al.
Pageof 6